Apyx Medical Corp financial data

Symbol
APYX on Nasdaq
Location
Clearwater, FL
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 496 % -10.6%
Quick Ratio 78 % -10.8%
Debt-to-equity 534 % +91.8%
Return On Equity -151 % +2.44%
Return On Assets -24.2 % +41.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 38.2M shares +10.4%
Common Stock, Shares, Outstanding 37.8M shares +9.17%
Entity Public Float 43.1M USD -74.3%
Common Stock, Value, Issued 38K USD +8.57%
Weighted Average Number of Shares Outstanding, Basic 40.7M shares +17.6%
Weighted Average Number of Shares Outstanding, Diluted 34.6M shares +0.12%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 47.9M USD -1.32%
Research and Development Expense 3.55M USD -33.9%
Operating Income (Loss) -9.51M USD +55.9%
Nonoperating Income (Expense) -4.75M USD -1.56%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -14.3M USD +49.6%
Income Tax Expense (Benefit) 265K USD +6%
Net Income (Loss) Attributable to Parent -14.5M USD +48.9%
Earnings Per Share, Basic 0 USD/shares +57.8%
Earnings Per Share, Diluted 0 USD/shares -74.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 25.1M USD -10.3%
Accounts Receivable, after Allowance for Credit Loss, Current 13M USD -0.32%
Inventory, Net 9.15M USD +1.61%
Assets, Current 48.8M USD -6.46%
Property, Plant and Equipment, Net 2.39M USD +25.5%
Operating Lease, Right-of-Use Asset 4.34M USD -9.92%
Other Assets, Noncurrent 1.81M USD +1.51%
Assets 57.4M USD -5.53%
Accounts Payable, Current 3.22M USD +68.2%
Employee-related Liabilities, Current 1.28M USD
Accrued Liabilities, Current 7.34M USD +0.73%
Contract with Customer, Liability, Current 515K USD -51.1%
Liabilities, Current 11M USD +14.9%
Contract with Customer, Liability, Noncurrent 1.22M USD -4.33%
Operating Lease, Liability, Noncurrent 4.17M USD -9.4%
Other Liabilities, Noncurrent 293K USD +45.8%
Liabilities 51.3M USD +3.56%
Retained Earnings (Accumulated Deficit) -87.8M USD -19.8%
Stockholders' Equity Attributable to Parent 5.85M USD -47%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 6.08M USD -45.7%
Liabilities and Equity 57.4M USD -5.53%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -702K USD +88.9%
Net Cash Provided by (Used in) Financing Activities 25K USD
Net Cash Provided by (Used in) Investing Activities -55K USD -57.1%
Common Stock, Shares Authorized 75M shares 0%
Common Stock, Shares, Issued 37.8M shares +9.17%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -730K USD +88.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 32.7M USD +76.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.15M USD -2.55%
Deferred Tax Assets, Valuation Allowance 20.7M USD +25.9%
Deferred Tax Assets, Gross 22.1M USD +22.3%
Operating Lease, Liability 4.82M USD -8.11%
Payments to Acquire Property, Plant, and Equipment 55K USD +57.1%
Lessee, Operating Lease, Liability, to be Paid 6.99M USD -10.3%
Property, Plant and Equipment, Gross 5.34M USD +6.04%
Operating Lease, Liability, Current 393K USD +19.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 824K USD +2.36%
Lessee, Operating Lease, Liability, to be Paid, Year One 797K USD +2.44%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.17M USD -14.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 852K USD +2.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 764K USD -11.2%
Additional Paid in Capital 93.6M USD +11.1%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 138K USD -12.1%
Deferred Tax Assets, Net of Valuation Allowance 1.36M USD -14.5%
Share-based Payment Arrangement, Expense 2.34M USD -42.8%
Interest Expense 4.52M USD +479%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%